Eton Pharmaceuticals (ETON) Depreciation and Depletion (2018 - 2025)

Eton Pharmaceuticals has disclosed Depreciation and Depletion across 8 years of filings, most recently posting $17000.0 for Q4 2025.

• Depreciation and Depletion for Q4 2025 came in at $17000.0, down 55.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $41000.0 (down 46.05% YoY), and the FY2025 annual result was $41000.0, down 18.0% from the prior year.
• Depreciation and Depletion came in at $17000.0 for Q4 2025 at Eton Pharmaceuticals, up from $8000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $84000.0 in Q1 2021 to a low of $4000.0 in Q2 2025.
• The 5-year median for Depreciation and Depletion is $13500.0 (2022), against an average of $19100.0.
• Across the five-year window, Depreciation and Depletion plunged 75.0% in 2022 and soared 216.67% in 2024, its largest moves.
• Eton Pharmaceuticals' Depreciation and Depletion stood at $23000.0 in 2021, then sank by 43.48% to $13000.0 in 2022, then retreated by 7.69% to $12000.0 in 2023, then jumped by 216.67% to $38000.0 in 2024, then plunged by 55.26% to $17000.0 in 2025.
• The last three Depreciation and Depletion figures came in at $17000.0 (Q4 2025), $8000.0 (Q3 2025), and $4000.0 (Q2 2025), per Business Quant data.